SurModics (SRDX) Tops Q3 EPS by 25c
Get Alerts SRDX Hot Sheet
Price: $26.17 +0.38%
EPS Growth %: +12.5%
Financial Fact:
Income (loss) from operations: 4.08M
Today's EPS Names:
FRSB, DGICA, UXIN, More
EPS Growth %: +12.5%
Financial Fact:
Income (loss) from operations: 4.08M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
SurModics (NASDAQ: SRDX) reported Q3 EPS of $0.37, $0.25 better than the analyst estimate of $0.12. Revenue for the quarter came in at $20 million versus the consensus estimate of $16.31 million.
For earnings history and earnings-related data on SurModics (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!